| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Molecular Diagnostics and Genetics |
1 Institute of Microbiology and Epidemiology, Academy of Military Medical Sciences, Beijing 100071, China.
aAddress correspondence to this author at: Institute of Microbiology and Epidemiology, Academy of Military Medical Science, 20, Dongdajie, Fengtai District, Beijing 100071, People’s Republic of China. Fax 86-10-83820748; e-mail yangrf{at}nic.bmi.ac.cn.
Background: The widespread threat of severe acute respiratory syndrome (SARS) to human health has made urgent the development of fast and accurate analytical methods for its early diagnosis and a safe and efficient antiviral vaccine for preventive use. For this purpose, we investigated the antigenicity of different regions of the SARS coronavirus (SARS-CoV) nucleocapsid (N) protein.
Methods: The cDNA for full-length N protein and its various regions from the SARS-CoV was cloned and expressed in Escherichia coli. After purification, all of the protein fragments were printed on glass slides to fabricate a protein microarray and then probed with the sera from SARS patients to determine the reactivity of these protein fragments.
Results: The full-length protein and two other fragments reacted with all 52 sera tested. Four important regions with possible epitopes were identified and named as EP1 (amino acids 51–71), EP2 (134–208), EP3 (249–273), and EP4 (349–422), respectively. EP2 and EP4 possessed linear epitopes, whereas EP1 and EP2 were able to form conformational epitopes that could react with most (>80%) of the tested sera. EP3 and EP4 also formed conformational epitopes, and antibodies against these epitopes existed in all 52 of the sera tested.
Conclusion: The N protein is a highly immunogenic protein of the SARS-CoV. Conformational epitopes are important for this protein, and antigenicity of the COOH terminus is higher than that of the NH2 terminus. The N protein is a potential diagnostic antigen and vaccine candidate for SARS-CoV.
The following articles in journals at HighWire Press have cited this article:
|
|
 |
|
  C. W. Yip, C. C. Hon, F. Zeng, K. Y. C. Chow, K. H. Chan, J. S. M. Peiris, and F. C. C. Leung Naturally Occurring Anti-Escherichia coli Protein Antibodies in the Sera of Healthy Humans Cause Analytical Interference in a Recombinant Nucleocapsid Protein-Based Enzyme-Linked Immunosorbent Assay for Serodiagnosis of Severe Acute Respiratory Syndrome Clin. Vaccine Immunol., January 1, 2007; 14(1): 99 - 101. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. J. McAfee, D. T. Duncan, M. Assink, and A. J. Link Analyzing Proteomes and Protein Function Using Graphical Comparative Analysis of Tandem Mass Spectrometry Results Mol. Cell. Proteomics, August 1, 2006; 5(8): 1497 - 1513. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S C S Chow, C Y S Ho, T T Y Tam, C Wu, T Cheung, P K S Chan, M H L Ng, P K Hui, H K Ng, D M Y Au, et al. Specific epitopes of the structural and hypothetical proteins elicit variable humoral responses in SARS patients J. Clin. Pathol., May 1, 2006; 59(5): 468 - 476. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 X. Zhong, Z. Guo, H. Yang, L. Peng, Y. Xie, T.-Y. Wong, S.-T. Lai, and Z. Guo Amino terminus of the SARS coronavirus protein 3a elicits strong, potentially protective humoral responses in infected patients J. Gen. Virol., February 1, 2006; 87(2): 369 - 373. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Liang, Y. Wan, L.-w. Qiu, J. Zhou, B. Ni, B. Guo, Q. Zou, L. Zou, W. Zhou, Z. Jia, et al. Comprehensive Antibody Epitope Mapping of the Nucleocapsid Protein of Severe Acute Respiratory Syndrome (SARS) Coronavirus: Insight into the Humoral Immunity of SARS Clin. Chem., August 1, 2005; 51(8): 1382 - 1396. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. Li, L. Jiang, Q. Song, J. Yang, Z. Chen, Z. Guo, D. Zhou, Z. Du, Y. Song, J. Wang, et al. Protein Microarray for Profiling Antibody Responses to Yersinia pestis Live Vaccine Infect. Immun., June 1, 2005; 73(6): 3734 - 3739. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 X. Zhong, H. Yang, Z.-F. Guo, W.-Y. F. Sin, W. Chen, J. Xu, L. Fu, J. Wu, C.-K. G. Mak, C.-S. S. Cheng, et al. B-Cell Responses in Patients Who Have Recovered from Severe Acute Respiratory Syndrome Target a Dominant Site in the S2 Domain of the Surface Spike Glycoprotein J. Virol., March 15, 2005; 79(6): 3401 - 3408. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Qiu, J. Wang, H. Wang, Z. Chen, E. Dai, Z. Guo, X. Wang, X. Pang, B. Fan, J. Wen, et al. Use of the COOH Portion of the Nucleocapsid Protein in an Antigen-Capturing Enzyme-Linked Immunosorbent Assay for Specific and Sensitive Detection of Severe Acute Respiratory Syndrome Coronavirus Clin. Vaccine Immunol., March 1, 2005; 12(3): 474 - 476. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. N. van den Brink, J. ter Meulen, F. Cox, M. A. C. Jongeneelen, A. Thijsse, M. Throsby, W. E. Marissen, P. M. L. Rood, A. B. H. Bakker, H. R. Gelderblom, et al. Molecular and Biological Characterization of Human Monoclonal Antibodies Binding to the Spike and Nucleocapsid Proteins of Severe Acute Respiratory Syndrome Coronavirus J. Virol., February 1, 2005; 79(3): 1635 - 1644. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
